Amneal Pharmaceuticals, Inc. AMRX Net Change in Cash
Net Change in Cash at other companies
Other financials
Where this comes from
Reported directly by Amneal Pharmaceuticals, Inc. in its filing.
Tagged under the XBRL concept us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect.
The official record: Amneal Pharmaceuticals, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Amneal Pharmaceuticals, Inc.'s net change in cash.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Amneal Pharmaceuticals, Inc.'s net change in cash?
- Amneal Pharmaceuticals, Inc. (AMRX) reported net change in cash of -$108.53M in Q1 2026.
- How has Amneal Pharmaceuticals, Inc.'s net change in cash changed year-over-year?
- Amneal Pharmaceuticals, Inc.'s net change in cash decreased by 116.9% year-over-year, from -$50.03M to -$108.53M.
- What is the long-term trend for Amneal Pharmaceuticals, Inc.'s net change in cash?
- Over 2 years (2022 to 2025), Amneal Pharmaceuticals, Inc.'s net change in cash has grown at a -6.3% compound annual growth rate (CAGR), from -$221.51M to $194.52M.
- What does net change in cash mean?
- Total increase or decrease in cash during the period — the sum of operating, investing, financing cash flows plus FX effects.